logo
Agilysys Launches Intelligent Guest Profiles at HITEC 2025 to Transform How Hoteliers Harness Guest Data to Expand Ancillary Revenue and Personalize Service

Agilysys Launches Intelligent Guest Profiles at HITEC 2025 to Transform How Hoteliers Harness Guest Data to Expand Ancillary Revenue and Personalize Service

Business Wirea day ago

ALPHARETTA, Ga. & INDIANAPOLIS--(BUSINESS WIRE)-- Agilysys, Inc. (Nasdaq: AGYS), a leading global provider of hospitality software and services, announced at HITEC 2025 Intelligent Guest Profiles – a transformative advance in how hotels and resorts harness robust guest data across Agilysys hospitality solutions to drive personalized service, smarter upselling, ancillary revenue and deeper loyalty.
Intelligent Guest Profile Services (IGPS) technology is powered by Agilysys guestsense.ai to provide a powerful, consistent, unified guest data search interface across all Agilysys hospitality applications. Guestsense.ai's contextual intelligence prioritizes results -- beyond simple alphabetical sorting – to more accurately anticipate which guest a staff member is searching for based on characteristics such as 'already in-house,' 'upcoming reservation' or 'recently checked out.' Profiles surface aggregated multi-amenity spend data, are easily accessed by staff and appear consistently across applications – advantages not possible with disparate software and siloed data.
IGPS unified search is enabled for Agilysys PMS systems (Versa, Stay and LMS) and across Agilysys ancillary revenue-related systems, including Spa, Golf, Reserve Dining and Activities, Membership and Book4Time.
While other 'unified' guest profile approaches typically share minimal information such as name, address, email and phone number, Agilysys Intelligent Guest Profiles leverage a services-based architecture with 'subscribe and sync' capabilities to continuously collect and share real-time behavioral, transactional and preference data across Agilysys software applications and properties, creating a complete view of each guest from a 'single pane of glass.' Intelligent Guest Profile services track and store data well beyond other guest profile offerings, and then make these insights accessible at every touchpoint. Data includes photos, preferences, detailed itineraries, related guest profiles and member and/or loyalty status.
Intelligent Guest Profiles also aggregate each guest's spending data and Recency, Frequency and Monetary (RFM) value metrics across transactions during each stay and over time so hoteliers can assess each guest's lifetime value. This behavioral data meaningfully improves personalized revenue management and optimization strategies. Consistently aggregating and sharing data in this way lays the groundwork for making more sophisticated use of Artificial Intelligence (AI) and machine learning in predictive and prescriptive guest promotion, retention and loyalty programs.
Intelligent Guest Profiles unlock these advantages for hoteliers:
Closer connections between staff and guests resulting from intuitive, easy access to guest data that provides deeper insights than what staff members can gain from less sophisticated profile technology
Elevated personalized guest experiences far beyond what previously has been possible
Smarter upselling in real-time at scale, driving higher Revenue per Guest
Superior guest satisfaction and loyalty resulting from more meaningful personalized service across all touchpoints
Enhanced staff efficiency gained through intuitive, consistent access to guest intelligence across the property
The ability to replace 'one-size-fits-all' guest relationships with data-driven, curated ones blending digital and high-touch interactions that are both personal and profitable
'Intelligent Guest Profiles represent a quantum leap forward in how guest data is collected, shared and used,' said Rohith Kori, Senior Vice President, Corporate and Product Strategy for Agilysys. 'The services-based, synchronized and aggregated data collection and sharing powered by guestsense.ai is light years ahead of the approaches other software providers have used in attempts to create unified guest profiles. The Agilysys Intelligent Guest Profile services technology meaningfully raises the bar for intelligently collecting and leveraging guest data to elevate personalized service and revenue across properties and amenities,' he added.
HITEC 2025 attendees can learn more about Intelligent Guest Profiles in two ways:
Visit Agilysys in Booth #1611 during the June 17 – 19 HITEC exhibition days
Attend How Intelligent Guest Profiles Make Hospitality Moments Matter: The Guest Perspective, presented by Rohith Kori on Wednesday, June 18, 11:15 a.m. – 11:45 a.m. in the Exhibit Hall, Tutorial Stage A: Booth 801
About Agilysys, Inc. (www.agilysys.com)
Agilysys exclusively delivers state-of-the-art hospitality software solutions and services that help organizations go beyond what they can accomplish with traditional property management systems (PMS), point-of-sale (POS) solutions and food and beverage inventory and procurement systems. Modern, state-of-the-art solutions work standalone to provide best-in-class capabilities, or together in a coordinated ecosystem that unifies data and workflows across a property, to equip staff members to delight guests, improve efficiency and grow margins.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Simplify Healthcare Launches Xperience1™: A Next-Generation Platform for Benefits Inquiry Management, Powered by Domain-Rich AI
Simplify Healthcare Launches Xperience1™: A Next-Generation Platform for Benefits Inquiry Management, Powered by Domain-Rich AI

Business Wire

time31 minutes ago

  • Business Wire

Simplify Healthcare Launches Xperience1™: A Next-Generation Platform for Benefits Inquiry Management, Powered by Domain-Rich AI

AURORA, Ill.--(BUSINESS WIRE)-- Simplify Healthcare, a recognized leader in enterprise software solutions for Payers, today announced Xperience1™, a groundbreaking solution designed to transform the benefits inquiry experience for health plan members, providers, brokers, and other stakeholders. This next-generation CX platform delivers clear, real-time, plain-language responses to complex benefit questions—across all channels and user roles. Built on the trusted Simplify Health Cloud™, Xperience1™ unifies the strengths of the company's flagship platforms, Service1™ and Experience1™, into one intelligent, AI-powered customer experience platform. It enables payers to streamline and elevate benefits communication across the entire member journey—from plan shopping and enrollment to customer service and self-service. 'Xperience1™ is the natural next step in our mission to transform how healthcare consumers understand, navigate, and experience their benefits,' said Ashish Desai, EVP and GM, Xperience1™, Simplify Healthcare. 'It delivers measurable business impact by significantly reducing call duration, improving first call resolution (FCR), and ensuring clear, consistent, member-friendly communication.' Unlike generic GenAI-based solutions that are prone to hallucinations, Xperience1™ is built on a robust architecture featuring a sophisticated domain-rich data foundation, intelligent content management, an interactive AI framework, and a built-in health literacy model. These capabilities enable it to provide accurate, context-aware, and curated responses—minimizing the risk of misinformation. ' With Xperience1™, we're going further—not starting over,' added Mohammed Vaid, CEO and Chief Solution Architect, Simplify Healthcare. ' We've reimagined two trusted solutions into one unified platform, delivering on our promise to bring clarity to complexity.' The launch of Xperience1™ underscores Simplify Healthcare's commitment to innovation and its mission to simplify the healthcare experience. To learn more about Xperience1™, visit About Simplify Healthcare Simplify Healthcare helps payers achieve growth and operational efficiency through its industry-leading platform, proven processes, and deep expertise. Founded in 2008, the company tackles some of the most complex challenges in healthcare by connecting the front, middle, and back office through a platform-centric, payer-focused approach.

Pioneering precision: GE HealthCare aims to elevate clinical care through total body PET/CT technology with Stanford Medicine
Pioneering precision: GE HealthCare aims to elevate clinical care through total body PET/CT technology with Stanford Medicine

Business Wire

time41 minutes ago

  • Business Wire

Pioneering precision: GE HealthCare aims to elevate clinical care through total body PET/CT technology with Stanford Medicine

CHICAGO--(BUSINESS WIRE)--Building on a collaboration that spans more than three decades, GE HealthCare has renewed its research collaboration with Stanford Medicine – with one of their key intentions being the development and research of innovative total body PET/CT technology. i This effort is expected to explore new clinical pathways and help enhance patient outcomes through innovative imaging solutions. 'This technology is designed to offer a level of sensitivity and spatial resolution that can change how we design and conduct molecular imaging studies,' says Dr. Andrei Iagaru, Division Chief of Nuclear Medicine and Molecular Imaging, Stanford Medicine. Share 'PET/CT has revolutionized the way we understand and treat disease by allowing us to visualize biological processes at the cellular level,' explains Dr. Quynh-Thu Le, interim Chair of the Department of Radiology, Stanford Medicine. 'With total body PET/CT, we can explore new frontiers. Not only do we expect it will be faster, but we also believe it will fundamentally expand what is possible in translational research.' Molecular imaging – and specifically the utilization of PET/CT scanners – offers opportunities for precision care across various disease states. It supports theranostics in oncology for advanced prostate cancer treatment, helps streamline radiation oncology workflows, aids in beta amyloid imaging for Alzheimer's evaluation and monitoring, and assists in myocardial perfusion evaluation for diagnosing coronary artery disease. Unlike other imaging procedures, PET/CT technology visualizes, characterizes, and quantifies biological processes at the cellular level, aiding in early disease identification, detailed assessment, and treatment planning. It is a non-invasive solution, providing critical insights that help enhance patient care and can support accelerated drug development. 'This technology is designed to offer a level of sensitivity and spatial resolution that can change how we design and conduct molecular imaging studies,' adds Dr. Andrei Iagaru, Division Chief of Nuclear Medicine and Molecular Imaging, Stanford Medicine. 'For example, such technological characteristics can create opportunities to reduce anesthesia use in pediatric imaging by dramatically shortening scan times and enable the exploration of dual-tracer studies and early diagnosis with far greater precision. Total body PET/CT technology is an ideal tool to evaluate biodistribution and dosimetry of new PET radiopharmaceuticals in our first human studies.' Knowing the potential of this technology, researchers at Stanford Medicine and engineers at GE HealthCare aim to advance a next-generation PET/CT designed to provide new opportunities to improve diagnosis, staging, therapeutic planning, and evaluation of treatment response across various care pathways. By leveraging the technology's capabilities, both institutions believe it has the potential to drive new clinical pathways, expedite the development and translation of new diagnostic and therapeutic agents, support existing molecular imaging and theranostics applications, and promote enhanced healthcare system efficiency. 'The high throughput we anticipate from this technology could ultimately help improve access for our patients and reduce wait times to their next appointment,' says Dr. Erin Grady, incoming Division Chief of Nuclear Medicine and Molecular Imaging, Stanford Medicine. GE HealthCare's total body PET/CT innovation In collaboration with a select group of leading healthcare institutions around the world, GE HealthCare aims to demonstrate how total body PET/CT imaging can overcome barriers that previously hindered widespread adoption of PET/CT beyond oncology. This initiative seeks to expand the use of PET with the goal of leveraging ultra-high sensitivity total body PET/CT technology to push the boundaries of oncology by significantly reducing scan time and the injected dose – important considerations for all patients, but particularly vulnerable patients like pediatrics, where ultra-fast scans can allow reduction in anesthesia and sedation in children. To support this advanced research, encourage new discoveries, and meet growing clinical demands, GE HealthCare designed its total body PET/CT technology with the goal of enabling ultra-low dose scans; fast acquisitions; multi organ dynamic imaging; and dual tracer imaging. All important factors that help improve diagnosis confidence. In parallel, the technology aims to improve healthcare system efficiency by enhancing clinical workflows, supporting routine clinical practice, and improving operational efficiency. 'At GE HealthCare, innovation is in our DNA. Our total body PET/CT technology represents the next chapter in our enduring commitment to advancing medical imaging,' adds Jean-Luc Procaccini, President & CEO, Molecular Imaging and Computed Tomography, GE HealthCare. 'We're proud to collaborate with world-class institutions to explore new clinical frontiers in oncology and beyond. Together with our MIM software solutions, we're designing flexible, AI-enhanced tools that not only aim to enhance diagnostic confidence and operational efficiency but also help clinicians deliver more precise, personalized care that can truly improve patient outcomes.' GE HealthCare has a long-standing history of and commitment to pioneering next-generation imaging technology. From the first commercially available PET/CT solution, Discovery LS, ii to the development of the first silicon-based photon counting computed tomography (CT) prototype, iii GE HealthCare continues to push the boundaries of medical imaging for the benefit of clinicians and patients worldwide. As such, GE HealthCare is at the forefront of driving a connected healthcare transformation and revolutionizing precision care. For more information on GE HealthCare's impressive Molecular Imaging portfolio, visit About GE HealthCare Technologies Inc. GE HealthCare is a trusted partner and leading global healthcare solutions provider, innovating medical technology, pharmaceutical diagnostics, and integrated, cloud-first AI-enabled solutions, services and data analytics. We aim to make hospitals and health systems more efficient, clinicians more effective, therapies more precise, and patients healthier and happier. Serving patients and providers for more than 125 years, GE HealthCare is advancing personalized, connected and compassionate care, while simplifying the patient's journey across care pathways. Together, our Imaging, Advanced Visualization Solutions, Patient Care Solutions and Pharmaceutical Diagnostics businesses help improve patient care from screening and diagnosis to therapy and monitoring. We are a $19.7 billion business with approximately 53,000 colleagues working to create a world where healthcare has no limits. GE HealthCare is proud to be among 2025 Fortune World's Most Admired Companies™.

Rosen Law Firm Urges Reddit, Inc. (NYSE: RDDT) Stockholders with Large Losses to Contact the Firm for Information About Their Rights
Rosen Law Firm Urges Reddit, Inc. (NYSE: RDDT) Stockholders with Large Losses to Contact the Firm for Information About Their Rights

Business Wire

time41 minutes ago

  • Business Wire

Rosen Law Firm Urges Reddit, Inc. (NYSE: RDDT) Stockholders with Large Losses to Contact the Firm for Information About Their Rights

NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action lawsuit on behalf of purchasers and acquirers of Reddit, Inc. (NYSE: RDDT) securities between October 29, 2024 and May 20, 2025, both dates inclusive (the 'Class Period'). Reddit is a social media platform and forum-style website. For more information, submit a form, email attorney Phillip Kim, or give us a call at 866-767-3653. The Allegations: Rosen Law Firm is Investigating the Allegations that Reddit, Inc. (NYSE: RDDT) Misled Investors Regarding its Business Operations. According to the lawsuit, throughout the Class Period, defendants made false and misleading statements and/or failed to disclose that: (1) changes in Google Search's algorithm and features like AI Overview were causing users to stop their query on Google search; (2) these algorithm changes were materially different than prior instances of reduced traffic to the Reddit website; (3) defendants were aware that the increase in the query term 'Reddit' on search engines was because users were getting the sought after answer from Google Search without having to go to Reddit, and not because they intended to visit Reddit; (4) this zero-click search reality was dramatically reducing traffic to Reddit in a manner that Reddit was unable to overcome in the short term; and (5) Defendants, therefore, lacked a reasonable basis for its outlook on user rates and advertising revenues. When the true details entered the market, the lawsuit claims that investors suffered damages. What Now: You may be eligible to participate in the class action against Reddit, Inc. Shareholders who want to serve as lead plaintiff for the class must file their motions with the court by August 18, 2025. A lead plaintiff is a representative party who acts on behalf of other class members in directing the litigation. You do not have to participate in the case to be eligible for a recovery. If you choose to take no action, you can remain an absent class member. For more information, click here. All representation is on a contingency fee basis. Shareholders pay no fees or expenses. About Rosen Law Firm: Some law firms issuing releases about this matter do not actually litigate securities class actions. Rosen Law Firm does. Rosen Law Firm is a recognized leader in shareholder rights litigation, dedicated to helping shareholders recover losses, improving corporate governance structures, and holding company executives accountable for their wrongdoing. Since its inception, Rosen Law Firm has obtained over $1 billion for shareholders. Attorney Advertising. Prior results do not guarantee a similar outcome.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store